Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Valley Fever 2016 NIAID 5R44AI102343-04 Molecular Detection of Invasive Fungal Infections LEVIN, ANDREW IMMUNETICS, INC. MA $999,952
Valley Fever 2016 NIAID 5R33AI101497-05 Optimized CYP51 Inhibitors for the Oral Treatment of CNS Coccidioides Infections GARVEY, EDWARD VIAMET PHARMACEUTICALS, INC. NC $95,000
Valley Fever 2016 NIAID 5R21AI114762-02 Enhancement of protective efficacy of Coccidioides vaccines by adjuvants HUNG, CHIUNG YU UNIVERSITY OF TEXAS SAN ANTONIO TX $191,815
Valley Fever 2016 NIAID 5R21AI117885-02 Vaccine Immunity to Attenuated Coccidioides FRELINGER, JEFFREY UNIVERSITY OF ARIZONA AZ $191,875
Valley Fever 2016 NIAID 5U01AI112406-03 Nikkomycin Z treatment of primary pneumonia due to Coccidioides LARWOOD, DAVID VALLEY FEVER SOLUTIONS, INC. AZ $859,330
Valley Fever 2016 NIAID 1R44AI125017-01 Developing a Novel, Fungicidal Therapeutic to Treat Coccidioidomycosis SHAW, KAREN AMPLYX PHARMACEUTICALS, INC. CA $728,595
Valley Fever 2016 NIAID 272201300017I-1-27200009-1 Phase IV Clinical Trial in Adults with Community Acquired Pneumonia to Assess the Effect of Early Empiric Antifungal Treatment of Coccidioidomycosis Pneumonia - VTEU NAGGIE, SUSANNA DUKE UNIVERSITY NC $1,674,270
Valley Fever 2016 NIAID 272201300017I-1-27200008-1 Phase IV Clinical Trial in Adults with Community Acquired Pneumonia to Assess the Effect of Early Empiric Antifungal Treatment of Coccidioidomycosis Pneumonia - VTEU NAGGIE, SUSANNA DUKE UNIVERSITY NC $364,065
Valley Fever 2016 NIAID 272201000038I-0-27200006-1 Task A98: Antifungal in vivo Efficacy Testing-Coccidioides PATTERSON, THOMAS UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $275,010
Valley Fever 2016 NIAID 1ZIAAI000647-25 Genes And Gene Products As Immunoadjuvants HOLLAND, STEVEN NIH $1,047,553
Valley Fever 2016 NIAID 272201600035C-0-0-1 A MUCOSAL PROPHYLACTIC VACCINE AGAINST COCCIDIOIDOMYCOSIS HAYDEN, CELINE APPLIED BIOTECHNOLOGY INSTITUTE CA $449,984
Valley Fever 2016 NIAID 272201100018I-0-27200009-1 Task A21: In vitro testing against fungal pathogens PATTERSON, THOMAS UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $80,010
Valley Fever 2016 NIAID 272201100022I-0-27200009-1 TO X9: OPTIMIZATION PK STUDIES MIRSALIS, JON SRI INTERNATIONAL CA $147,459


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer